Research ethics III: Publication practices and authorship, conflicts of interest, and research misconduct

Journal of Speech, Language, and Hearing Research

Volumn 54, Issue 1, 2011, Pages

  Horner, Jennifer ^a   Minifie, Fred D ^b  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Authorship; Conflict of interest; Publication practices; Research misconduct; Responsible conduct of research; Scientific integrity

Indexed keywords

ANIMAL; CONFLICT OF INTEREST; ETHICS; HUMAN; MEDICAL RESEARCH; PUBLICATION; REVIEW; SCIENTIFIC MISCONDUCT; WRITING;

ANIMALS; AUTHORSHIP; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; HUMANS; PUBLICATIONS; SCIENTIFIC MISCONDUCT;

EID: 79551714353     PISSN: 10924388     EISSN: None     Source Type: Journal    
DOI: 10.1044/1092-4388(2010/09-0263)     Document Type: Article

References (174)

1. Abbs, J. H., Hartman, D. E.,& Vishwanat, B. (1987). Orofacial motor control impairment in Parkinson's disease. Neurology, 37, 394-398. (Pubitemid 17031733)
2. [retraction in Neurology 1996, 47(2), 340].
3. Abbs v. Sullivan, 963 F.2d 918 (7th Cir. 1992).
4. Adams, D.,& Pimple, K. D. (2005). Research misconduct and crime lessons from criminal science on preventing misconduct and promoting integrity. Accountability in Research, 12, 225-240.
5. Al-Marzouki, S., Evans, S., Marshall, T.,& Roberts, I. (2005). Are these data real? Statistical methods for the detection of data fabrication in clinical trials. BMJ, 331, 267-270. (Pubitemid 41097910)
6. Altman, D. G. (1994). The scandal of poor medical research: We need less research, better research, and research done for the right reasons [Editorial]. BMJ, 308, 283-284. (Pubitemid 24084135)
7. Alt-White, A. C.,& Pranulis, M. F. (2006). Addressing nurses' ethical concerns about research in critical care settings. Nursing Administration Quarterly, 30, 67-75.
8. American Medical Association. (1990). Conflicts of interest in biomedical research. JAMA: Journal of the American Medical Association, 263, 2790-2793.
9. American Medical Association. (2001). Principles of medical ethics. Retrieved from http://www.ama-assn.org/ ama/pub/physician-resources/medical- ethics/code-medicalethics/ principles-medical-ethics.shtml.
10. American Medical Association. (2007). AMA manual of style (10th ed.). New York, NY: Oxford University Press.
11. American Medical Association, Council on Ethical and Judicial Affairs. (1999). Opinion 8.031-Conflicts of Interest: Biomedical Research. Retrieved from http://www.Ama-assn.org/ama/pub/physician-resources/medical-ethics/ code-medical-ethics/opinion8031.shtml.
12. American Psychological Association. (2001). Publication manual of the American Psychological Association (5th ed.). Washington, DC: Author.
13. American Psychological Association. (2003). Ethical principles of psychologists and code of conduct. Washington, DC: Author. Retrieved from http://www.apa.org/ethics/ code2002.html.
14. American Psychological Association. (2010). Publication manual of the American Psychological Association (6th ed.). Washington, DC: Author.
15. American Speech-Language-Hearing Association. (2003). Code of ethics. ASHA Supplement, 23, 13-15. Rockville, MD: Author. Retrieved from http://www.asha.org/docs/ html/ET2003-00166.html.
16. Anderson, L. C. (2007). Institutional and IACUC responsibilities for animal care and use education and training programs. Institute for Laboratory Animal Research (ILAR) Journal, 48, 90-95.
17. Anderson, M. S., Horn, A. S., Risbey, K. R., Ronning, E. A., de Vries, R.,& Martinson, B. C. (2007). What do mentoring and training in the responsible conduct of research have to do with scientists' misbehavior? Findings from a national survey of NIH-funded scientists. Academic Medicine, 82, 853-860. (Pubitemid 47339815)
18. Anderson,M. S., Louis, K. S.,&Earle, J. (1994). Disciplinary and departmental effects on observations of faculty and graduate student misconduct. Journal of Higher Education, 65, 331-350.
19. Anderson, M. S., Ronning, E. A., de Vries,R.,&Martinson, B. C. (2007). The perverse effects of competition on scientists' work and relationships. Science and Engineering Ethics, 13, 437-461.
20. Angell, M. (1993). The doctor as double agent. Kennedy Institute of Ethics Journal, 3, 287-292.
21. Appelbaum, P. S., Roth, L. H., Lidz, C. W., Benson, P.,& Winslade, W. (1987). False hopes and best data: Consent to research and the therapeutic misconception. Hastings Center Report, 17, 20-24.
22. Association of American Medical Colleges, AAMC Task Force on Financial Conflicts of Interest in Clinical Research. (2003a). Protecting subjects, preserving trust, promoting progress. I: Policy and guidelines for the oversight of individual financial interest in human subjects research. Academic Medicine, 78, 225-236.
23. Association of American Medical Colleges, AAMC Task Force on Financial Conflicts of Interest in Clinical Research. (2003b, February). Protecting subjects, preserving trust, promoting progress. II: Principles and recommendations for oversight of an institution's financial interests in human subjects research. Academic Medicine, 78, 237-245.
24. Barrett, K. A., Funk, C. L.,& Macrina, F. L. (2005). Awareness of publication guidelines and the responsible conduct of research. Accountability in Research: Policies and Quality Assurance, 12, 193-206.
25. Benos, D. J., Fabres, J., Farmer, J., Gutierrez, J. P., Hennessy, K., Kosek, D., . . . Wang, K. (2005). Ethics and scientific publication. Advances in Physiology Education, 29, 59-74. (Pubitemid 41003031)
26. Berge v. University of Alabama, 104 F. 3d 1453 (4th Cir. 1997).
27. Bilic-Zulle, L., Azman, J., Frkovic, V., & Petrovecki, M. (2008). Is there an effective approach to deterring students from plagiarizing? Science and Engineering Ethics, 14, 139-147.
28. Blumsohn, A. (2006, Summer). Authorship, ghost-science, access to data and control of the pharmaceutical scientific literature: Who stands behind the word? Professional Ethics Report, 19, 1-4.
29. Bodenheimer, T. (2000). Uneasy alliance-Clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342, 1539-1544. (Pubitemid 30318291)
30. Bouville, M. (2008). Plagiarism:Words and ideas. Science and Engineering Ethics, 14, 311-322.
31. Bradley, S. G. (2005). Managing competing interests. In F. L. Macrina ( Ed.), Scientific integrity: Text and cases in responsible conduct of research (3rd ed., pp. 159-186). Washington, DC: ASM Press.
32. Braxton, J. M.,& Bayer, A. E. (1994). Perceptions of research misconduct and an analysis of their correlates. The Journal of Higher Education, 65, 351-372.
33. Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., . . . Smelser, N. (2006). Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA: Journal of the American Medical Association, 295, 429-433. (Pubitemid 43144979)
34. Broad,W. J., &Wade, N. (1982). Betrayers of the truth: Fraud and deceit in the halls of science. New York, NY: Oxford University Press.
35. Broccolo, B. M.,& Klanica, K. E. (2006). Conflicts of interest in human subject research: Adapting to evolving best practice standards. Medical Research Law& Policy Report, 6, 690-699.
36. Buchkowsky, S. S.,& Jewesson, P. J. (2004). Industry sponsorship and authorship of clinical trials over 20 years. Annals of Pharmacotherapy, 38, 579-585. (Pubitemid 38352217)
37. Budd, J. M., Sievert, M. E.,& Schultz, T. R. (1998). Phenomena of retraction: Reasons for retraction and citations to the publications. JAMA: Journal of the American Medical Association, 280, 296-297. (Pubitemid 28493915)
38. Cantekin v. University of Pittsburgh, 192 F.3d 402 (3rd Cir.1999).
39. Cantekin v. University of Pittsburgh, 192 F.3d 402 (3rd Cir. 1999). Claxton, L. D. (2005a). Scientific authorship Part 1. Awindow into scientific fraud? Mutation Research, 589, 17-30. (Pubitemid 40094589)
40. Claxton, L. D. (2005b). Scientific authorship Part 2. History, recurring issues, practices, and guidelines. Mutation Research, 589, 31-45. (Pubitemid 40094590)
41. Cohen, J. J. (2001). Trust us to make a difference: Ensuring public confidence in the integrity of clinical research. Academic Medicine, 76, 209-214. (Pubitemid 32151890)
42. Cokol,M., Iossifov, I., Rodriquez-Estaban, R.,&Rzhetsky, A. (2007). How many papers should be retracted? EMBO Reports (European Molecular Biology Organization), 8, 422-423. (Pubitemid 46696507)
43. Committee on Publication Ethics. (2000). Guidelines on good publication practice. Journal of Urology, 163, 249-252.
44. Committee on Publication Ethics. (2005). The COPE report 2005. Retrieved from http://publicationethics.org/ files/u2/2005-report.pdf.
45. Cowell, H. R. (2000). Ethical responsibilities of editors, reviewers, and authors. Clinical Orthopaedics and Related Research, 378, 83-89.
46. Coyne, J. (2005). Lessons in conflict of interest: The construction of the martyrdom of David Healy and the dilemma of bioethics. American Journal of Bioethics, 5, W3-W14. (Pubitemid 41674006)
47. Dahlberg, J. (2007). ORI retains its working definition of plagiarism under new regulations. Office of Research Integrity Newsletter, 15, 4.
48. Dahlberg, J. E.,& Mahler, C. C. (2006). The Poehlman case: Running away from the truth. Science and Engineering Ethics, 12, 157-173. (Pubitemid 43242438)
49. Daroff, R. B. (2005). Report from the Neurology scientific integrity advisor: Year 1. Neurology, 64, 588-589. (Pubitemid 40261881)
50. Daroff, R. B. (2007). Report from the scientific integrity advisor: Issues arising in 2005 and 2006. Neurology, 68, 1841-1842. (Pubitemid 46791399)
51. Davidoff, F., DeAngelis, C. D., Drazen, J. M., Hoey, J., Hojgaard, L., Horton, R., . . . Wilkes, M. S. (2001). Sponsorship, authorship, and accountability. The Lancet, 358, 854-856. (Pubitemid 32900562)
52. Davis, M. S. (2003). The role of culture in research misconduct. Accountability in Research, 10, 189-201.
53. Davis, M. S., Riske-Morris, M.,& Diaz, S. R. (2007). Causal factors implicated in research misconduct: Evidence from ORI case files. Science and Engineering Ethics, 13, 395-414.
54. DeAngelis, C. D., Fontanarosa, P. B.,& Flanagin, A. (2001). Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA: Journal of the American Medical Association, 286, 89-91. (Pubitemid 32606337)
55. De Vries, R., Anderson, M. S.,& Martinson, B. C. (2006). Normal misbehavior: Scientists talk about the ethics of research. Journal of Empirical Research on Human Research Ethics, 1, 43-50.
56. Drenth, J. P. H. (1998). Multiple authorship: The contribution of senior authors. JAMA: Journal of the American Medical Association, 280, 219-221. (Pubitemid 28493886)
57. Emanuel, E. J. (2005). Undue inducement: Nonsense on stilts? American Journal of Bioethics, 5, 9-13.
58. False Claims Act (1863). 18 U.S.C. x1001 et seq.
59. False Claims Amendments Act of 1986. Pub. L. 99-562, 100 Stat. 3153.
60. Flanagin, A., Carey, L. A., Fontanarosa, P. B., Phillips, S. G., Pace, B. P., Lundberg, G. D.,& Rennie, D. (1998). Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA: Journal of the American Medical Association, 280, 222-224. (Pubitemid 28493887)
61. Food and Drug Administration. (2006). Anne L. Butkovitz; Debarment order. Federal Register, 70, 61061.
62. Fox, M. F. (1994). Scientific misconduct and editorial and peer review processes. Journal of Higher Education, 65, 298-309.
63. Frazzetto, G. (2004). Who did what? (Uneasiness with the current authorship system is prompting the scientific community to seek alternatives). EMBO Reports (European Molecular Biology Organization), 5, 446-448.
64. Friedman, L. S.,& Richter, E. D. (2004). Relationship between conflicts of interest and research results. Journal of General Internal Medicine, 19, 51-56. (Pubitemid 38221951)
65. Gardner, W., Lidz, C. W.,& Hartwig, K. C. (2005). Authors' reports about research integrity problems in clinical trials. Contemporary Clinical Trials, 26, 244-251. (Pubitemid 40693611)
66. Garrison, H. H., Gerbi, S. A.,& Kincade, P. W. (2003). In an era of scientific opportunity, are there opportunities for biomedical scientists? FASEB Journal, 17, 2169-2173. (Pubitemid 37509570)
67. Goldner, J. A. (1998). The unending saga of legal controls over scientific misconduct: A clash of cultures needing resolution. American Journal of Law& Medicine, 24, 293-343. (Pubitemid 28374136)
68. Hamilton, D. P. (1994). In the trenches, doubts about scientific integrity: American Association for the Advancement of Science survey about scientific misconduct investigations. Science, 255, 1636.
69. Hamilton, D. P. (1997). Verdict in sight in the "BaltimoreCase. " In D. Elliott& J. E. Stern (Eds.), Research ethics: A reader (pp. 52-59). Hanover, NH: University Press of New England.
70. Harding, T. S., Carpenter, D. D., Finelli, D. J.,& Passow, H. J. (2004). Does academic dishonesty relate to unethical behavior in professional practice? An exploratory study. Science and Engineering Ethics, 10, 311-324. (Pubitemid 38648697)
71. Heitman, E., Anestidou, L., Olsen, C.,& Bulger, R. E. (2005). Do researchers learn to overlook misbehavior? Hastings Center Report, 35, 49.
72. Hilts, P. J. (1997). The science mob: The David Baltimore case-And its lessons. In D. Elliott& J. E. Stern ( Eds.), Research ethics: A reader ( pp. 43-51). Hanover, NH: University Press of New England.
73. Hoey, J. (2000). Who wrote this paper anyway? The new Vancouver Group statement refines the definition of authorship. Canadian Medical Association Journal, 163, 716-717.
74. Horner, J.,& Minifie, F. D. (2011a). Research ethics I: Responsible conduct of research (RCR)-Historical and contemporary issues pertaining to human and animal experimentation. Journal of Speech, Language, and Hearing Research, 54(Suppl.), S303-S329.
75. Horner, J.,& Minifie, F. D. (2011b). Research ethics II: Mentoring, collaboration, peer review, and data management and ownership. Journal of Speech, Language, and Hearing Research, 54(Suppl.), S330-S345.
76. Horton, R. (2002). The hidden research paper. JAMA: Journal of the American Medical Association, 287, 2775-2778. (Pubitemid 34591961)
77. Huth, E. J. (1986a). Abuses and uses of authorship. Annals of Internal Medicine, 104, 266-267.
78. Huth, E. J. (1986b). Irresponsible authorship and wasteful publication. Annals of Internal Medicine, 104, 257-259. (Pubitemid 16134718)
79. Ingham, J. C.,& Horner, J. (2004, March). Ethics and research [Feature]. The ASHA Leader. Retrieved from http://www.asha.org/Publications/ leader/2004/040316/ f040316c.htm.
80. Ingham, J. C., Minifie, F. D., Horner, J., Robey, R. R., Lansing, C., McCartney, J. H., . . . Moss, S. E. (2011). Ethical principles associated with the publication of research in ASHA's scholarly journals: Importance and adequacy of coverage. Journal of Speech, Language, and Hearing Research, 54(Suppl.), S394-S416.
81. International Committee of Medical Journal Editors. (2010). Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication. Retrieved from http://www.icmje.org/urm- full.pdf.
82. Janssen, R. L. (2003). Researcher liability for negligence in human subject research: Informed consent and researcher malpractice actions. Washington Law Review, 78, 229-260.
83. Jennings, R. C. (2004). Data selection and responsible conduct: Was Millikan a fraud? Science& Engineering Ethics, 10, 639-653. (Pubitemid 39563816)
84. Kalb, P. E.,& Koehler, K. G. (2002). Legal issues in scientific research. JAMA: Journal of the American Medical Association, 287, 85-91. (Pubitemid 34251680)
85. Kelly, R. E., Cohen, L. J., Semple, R. J., Bialer, P., Lau, A., Bodenheimer, A., . . . Galynker, I. I. (2006). Relationship between drug company funding and outcomes of clinical psychiatric research. Psychological Medicine, 36, 1647-1656. (Pubitemid 44575810)
86. Keranen, L. (2006). Assessing the seriousness of research misconduct: Considerations for sanction assignment. Accountability in Research, 13, 179-205.
87. Kim, S. Y., Millard, R. W., Nisbet, P., Cox, C.,& Caine, E. D. (2004). Potential research participants' views regarding researcher and institutional conflicts of interest. Journal of Medical Ethics, 30, 73-79. (Pubitemid 38262813)
88. Kimmelman, J. (2007). The therapeutic misconception at 25: Treatment, research, and confusion. Hastings Center Report, 37, 36-42.
89. Kinitisch, E. (2005). Researcher faces prison for fraud in NIH grant applications and papers. Science, 307, 1851.
90. Kjaergard, L. L.,& Als-Nielsen, B. (2002). Association between competing interests and authors' conclusions: Epidemiological study of randomised clinical trials published in the BMJ. BMJ, 325, 249-252. Retrieved from http://www.bmj.com/cgi/reprint/325/7358/249. (Pubitemid 34864391)
91. Klanica, K. (2005). Conflicts of interest in medical research: How much conflict should exceed legal boundaries? Journal of Biolaw& Business, 8, 37-45.
92. Koppelman-White, E. (2006). Research misconduct and the scientific process: Continuing quality improvement. Accountability in Research, 13, 225-246.
93. Krimsky, S. (2007). When conflict-of-interest is a factor in scientific misconduct. Medicine and Law, 26, 447-463. (Pubitemid 47629170)
94. Lexchin, J., Beros, L. A., Djulbegovic, B.,& Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ, 326, 1167-1177.
95. Martinson, B. C., Anderson, M. S., Crain, A. L.,& de Vries, R. (2006). Scientists' perceptions of organizational justice and self-reported misbehaviors. Journal of Empirical Research on Human Research Ethics, 1, 51-66.
96. Martinson, B. C., Anderson, M. S.,& de Vries, R. (2005). Scientists behaving badly. Nature, 435, 737-738. (Pubitemid 40839708)
97. Marusic, A., Katavic, V.,& Marusic, M. (2007). Role of editors and journals in detecting and preventing scientific misconduct: Strengths, weaknesses, opportunities, and threats. Medicine and Law, 26, 545-566. (Pubitemid 47629177)
98. McCrary, S. V., Anderson, C. B., Jakovljevic, J., Khan, T., McCullough, L. B., Wray, N. P.,& Brody, B. A. (2000). A national survey of policies on disclosure of conflicts of interest in biomedical research. New England Journal of Medicine, 343, 1621-1626. (Pubitemid 32162987)
99. Mello, M. M.,& Brennan, T. A. (2003). Due process in investigations of research misconduct. New England Journal of Medicine, 349, 1280-1286. (Pubitemid 37152039)
100. Miller, F. G.,& Joffe, S. (2006). Evaluating the therapeutic misconception. Kennedy Institute of Ethics Journal, 16, 353-366.
101. Miller, F. G.,& Rosenstein, D. L. (2003). The therapeutic orientation to clinical trials. New England Journal of Medicine, 348, 1383-1386. (Pubitemid 36384108)
102. Minifie, F. D., Robey, R. R., Horner, J., Ingham, J. C., Lansing, C., McCartney, J. H., . . . Moss, S. E. (2011). Responsible conduct of research in communication sciences and disorders: Faculty and student perceptions. Journal of Speech, Language, and Hearing Research, 54(Suppl.), S363-S393.
103. Morin, K., Rakatansjy, H., Riddick, F. A., Morse, L. J., O'Bannon, J. M., III, Goldrich, M. S., . . . Spillman, M. A. (2002). Managing conflicts of interest in the conduct of clinical trials. JAMA: Journal of the American Medical Association, 287, 78-84. (Pubitemid 34251679)
104. National Bioethics Advisory Commission. (2001). Ethical and policy issues in research involving human participants: Vol. 1. Retrieved from http://bioethics.georgetown.edu/nbac/ human/overvol1.html.
105. National Institutes of Health. (2004). Scientific peer review of research grant applications and research and development contract projects (final rule). Federal Register, 69, 272-278.
106. National Research Council, Committee on National Needs for Biomedical and Behavioral Scientists, Education and Career Studies Unit,& Office of Scientific and Engineering Personnel. (2000). Addressing the nation's changing needs for biomedical and behavioral scientists. Washington, DC: National Academies Press. Retrieved from http://www.nap.edu/catalog.php? record-id=9827.
107. National Science Foundation. (2002). Research misconduct (final rule). Federal Register, 67, 11936-11939.
108. Neale, A. V., Northrup, J., Dailey, R., Marks, E.,& Abrams, J. (2007). Correction and use of biomedical literature affected by scientific misconduct. Science and Engineering Ethics, 13, 5-24.
109. Office of Research Integrity. (n.d.). About ORI-History. Rockville, MD: Author. Retrieved from http://www.ori.dhhs.Gov/about/history.shtml.
110. Office of Research Integrity. (n.d.). Handling misconduct: Administrative actions. Rockville, MD: Author. Retrieved from http://ori.hhs.gov/misconduct/ admin-actions.shtml.
111. Office of Research Integrity. (n.d.). Legal concerns: Federal court decisions. Rockville, MD: Author. Retrieved from http://ori.hhs.gov/misconduct/ Legal-Rulings.shtml.
112. Office of Research Integrity. (1992). U.S. DHHS, statement of organization, functions and delegation of authority. Federal Register, 57, 24262-24263.
113. Office of Research Integrity. (1994). ORI policy on plagiarism. Rockville, MD: Author. Retrieved from http://www.ori.Dhhs.gov/policies/ plagiarism.shtml.
114. Office of Research Integrity. (1996a). James H. Abbs, Ph.D., University of Wisconsin-Madison [Case summary]. ORI Newsletter, 4, 4-5. Retrieved from http://ori.hhs.gov/ documents/newsletters/vol4-no3.pdf.
115. Office of Research Integrity. (1996b). Thereza Imanishi- Kari. ORI Newsletter, 4, 1.Retrieved from http://ori.dhhs.gov/ documents/newsletters/vol4- no4.pdf.
116. Office of Research Integrity. (2000). Final PHS policy for instruction in the responsible conduct of research [Announcement]. Federal Register, 65(236), 76647. Retrieved from http://www.ori.dhhs.gov/policies/RCR-Policy.shtml.
117. Office of Research Integrity. (2003). Annual report 2002. Rockville, MD: Author. Retrieved from http://ori.dhhs.gov/ documents/annual-reports/ori-annual- report-2002.pdf.
118. Office of Research Integrity. (2004). Annual report 2003. Rockville, MD: Author. Retrieved from http://ori.dhhs.gov/ documents/annual-reports/ori-annual- report-2003.pdf.
119. Office of Research Integrity. (2005a). Annual report 2004. Rockville, MD: Author. Retrieved from http://ori.dhhs.gov/ documents/annual-reports/ori- annual-report-2004.pdf.
120. Office of Research Integrity. (2005b). Federal Register findings of scientific misconduct notice: Dr. Eric T. Poehlman. Federal Register, 70, 15092-15095.
121. Office of Research Integrity. (2006a). Finding of debarment notice: Paul Kornak, Stratton VA Medical Center. Federal Register, 71, 9555-9556.
122. Office of Research Integrity. (2006b). Annual report 2005. Rockville, MD: Author. Retrieved from http://ori.dhhs.gov/ documents/annual-reports/ori- annual-report-2005.pdf.
123. Office of Research Integrity. (2007). Annual report 2006. Rockville, MD: Author. Retrieved from http://ori.dhhs.gov/ documents/annual-reports/ori-annual- report-2006.pdf.
124. Parrish, D.,& Noonan, B. (2009). Image manipulation as research misconduct. Science and Engineering Ethics, 15, 161-167.
125. Pascal, C. B. (2006). Complainant issues in research misconduct: The Office of Research Integrity experience. Experimental Biology and Medicine, 231, 1264-1270. (Pubitemid 44050473)
126. Perlis, C. S., Harwood, M.,& Perlis, R. H. (2005). Extent and impact of industry sponsorship conflicts of interest in dermatology research. Journal of the American Academy of Dermatology, 52, 967-971. (Pubitemid 40732534)
127. Phinney v. Verbrugge, 564 N.W.2d 532 (Mich. App. 1997).
128. Phinney v. Verbrugge, 564 N.W.2d 532 (Mich. App. 1997). Price, A. R. (1994). Definitions and boundaries of research misconduct. Journal of Higher Education, 65, 286-297.
129. Public Health Service. (2004). Financial relationships and interests in research involving human subjects: Guidance for human subject protection. Federal Register, 69, 26393-26397.
130. Public Health Service. (2005). Public Health Service policies on research misconduct (final rule). Federal Register, 70, 28370-28400.
131. Redman, B. K.,& Caplan, A. L. (2005). Off with their heads: The need to criminalize some forms of scientific misconduct. Journal of Law, Medicine& Ethics, 33, 345-348. (Pubitemid 41196998)
132. Redman, B. K.,& Merz, J. F. (2008). Scientific misconduct: Do the punishments fit the crime? Science, 321, 775.
133. Redman, B. K., Templin, T. N.,& Merz, J. F. (2006). Research misconduct among clinical trial staff. Science and Engineering Ethics, 12, 481-489. (Pubitemid 44337999)
134. Rennie, D., Yank, V.,& Emanuel, L. (1997). When authorship fails: A proposal to make contributors accountable. JAMA: Journal of the American Medical Association, 278, 579-585. (Pubitemid 27353608)
135. Reynolds, S. M. (2004). ORI findings of scientific misconduct in clinical trials and publicly funded research 1992-2002. Clinical Trials, 1, 475-476.
136. Roberts, L. (1997). Misconduct: Caltech's trial by fire. In D. Elliott& J. E. Stern ( Eds.), Research ethics: A reader ( pp. 60-68). Hanover, NH: University Press of New England.
137. Schroter, S., Morris, J., Chaudhry, S., Smith, R.,& Barratt, H. (2004). Does the type of competing interest statement affect readers' perception of the credibility of research? BMJ, 328, 742-743. (Pubitemid 38406427)
138. Schulman, K. A., Seils, D. M., Timbie, J.W., Sugarman, J., Dame, L. A., Weinfurt, K. P., . . . Califf, R. M. (2002). A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. New England Journal of Medicine, 347, 1335-1341. (Pubitemid 35215325)
139. Shamoo, A. E.,& Resnik, D. B. (2003). Responsible conduct of research. New York, NY: Oxford University Press.
140. Sharav, V. H. (2006). Scientific fraud: Eric Poehlman/Richard Boris on. Retrieved from http://www.ahrp.org/cms/content/ view/370/150.
141. Sharp, R. R.,& Yarborough, M. (2006). Currents in contemporary ethics: Informed trust and the financing of biomedical research. Journal of Law, Medicine& Ethics, 34, 460-463.
142. Sherman, S. A. (1995). The False Claims Act: Litigating scientific misconduct. Public Health Reports, 110, 784-789.
143. Sherman, S. A. (1997). The False Claims Act: Litigating scientific misconduct II. Public Health Reports, 112, 248.
144. Singer, N. (2009, August 18). Senator moves to block medical ghostwriting. New York Times [Business section], B1. Retrieved from http://www.nytimes.com/2009/08/19/health/ research/19ethics.html.
145. Sollitto, S., Hoffman, S., Mehlman, M., Lederman, R. J., Youngner, S. J.,& Lederman, M. M. (2003). Intrinsic conflicts of interest in clinical research: A need for disclosure. Kennedy Institute of Ethics Journal, 13, 83-91. (Pubitemid 37130488)
146. Sox, H. C.,& Rennie, D. (2006). Research misconduct, retraction, and cleansing the medical literature: Lessons from the Poehlman case. Annals of Internal Medicine, 144, E7-E11.
147. Steinberg, N. A. (2000). Regulation of scientific misconduct in federally funded research. Southern California Interdisciplinary Law Journal, 10, 39-105.
148. Steneck, N. H. (1994). Research universities and scientific misconduct: History, policies and the future. Journal of Higher Education, 65, 310-330.
149. Steneck, N. H. (2002). Assessing the integrity of publicly supported research. In N. H. Steneck&M. D. Scheetz ( Eds.), Investigating research integrity, proceedings of the first ORI research conference on research integrity (pp. 1-16). Rockville, MD: Office of Research Integrity.
150. Stossel, T. P. (2005). Regulating academic-industrial research relationships-Solving problems or stifling progress? New England Journal of Medicine, 353, 1060-1065. (Pubitemid 41262343)
151. Strange, K. (2008). Authorship: Why not just toss a coin? American Journal of Physiology-Cell Physiology, 295, C567-C575.
152. Studdert, D. M., Mello, M. M.,& Brennan, T. A. (2004). Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-Self-regulation in the shadow of federal prosecution. New England Journal of Medicine, 351, 1891-1900. (Pubitemid 39426326)
153. Swazey, J. P., Anderson, M. S.,& Lewis, K. S. (1993). Ethical problems in academic research. American Scientist, 81, 542-553.
154. Trikalinos, N. A., Evangelou, E.,& Ioannidis, J. P. A. (2008). Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers. Journal of Clinical Epidemiology, 6, 464-470. (Pubitemid 351446189)
155. United States of America v. Butkovitz, Criminal No. 05-CR- 10128-DPW (U.S. Dist. Ct., D. Mass., May 25, 2005).
156. United States of America, ex rel. Walter F. DeNino v. Eric T. Poehlman, Ph.D., No. 1:04-CV-310 (D.Vt. March 21, 2005).
157. United States of America v. Eric T. Poehlman, Criminal No. 2:05-cc-38-1 [Criminal information] (D.Vt. March 21, 2005a).
158. United States of America v. Eric T. Poehlman, No. 2:05-cv-66 [Settlement agreement and stipulation for entry of judgment] (D. Vt. March 21, 2, 2005b).
159. United States of America v. Paul H. Kornak, Criminal Action No. 03-CR-436 (FJS), U.S. District Court (N.D.N.Y., January 18, 2005). Retrieved from http://www.circare.org/lex/ 03cr436.pdf.
160. Vasgird, D. R. (2007). Prevention over cure: The administrative rationale for education in the responsible conduct of research. Academic Medicine, 82, 835-837. (Pubitemid 47339812)
161. Wagena, E. J. (2005). The scandal of unfair behaviour of senior faculty. Journal of Medical Ethics, 31, 308. Doi: 10.1136/jme.2004.009308. (Pubitemid 40691682)
162. Weinfurt, K. P., Dinan, M. A., Allsbrook, J. S., Friedman, J. Y., Hall, M. A., Schulman, K. A.,& Sugarman, J. (2006). Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Academic Medicine, 81, 113-118. (Pubitemid 44356688)
163. Weinfurt, K. P., Friedman, J. Y., Dinan, M. A., Allsbrook, J. S., Hall, M. A., Khillon, J. K.,& Sugarman, J. (2006). Disclosing conflicts of interest in clinical research: Views of institutional review boards, conflict of interest committees, and investigators. Journal of Law, Medicine& Ethics, 34, 581-591. (Pubitemid 44505518)
164. Weinfurt, K. P., Hall, M. A., Dinan, M. A., DePuym, V., Friedman, J. Y., Allsbrook, J. S.,& Sugarman, J. (2008). Effects of disclosing financial interests on attitudes toward clinical research. Journal of General Internal Medicine, 23, 860-866.
165. Wendler, D. (2004). Deception in the pursuit of science. Archives of Internal Medicine, 164, 597-600. (Pubitemid 38392973)
166. Wenger, N. S., Korenman, S. G., Berk, R.,& Liu, H. (1998). Punishment for unethical behavior in the conduct of research. Academic Medicine, 73, 1187-1194. (Pubitemid 28530293)
167. Werhane, P.,& Doering, J. (1997). Conflict of interest and conflicts of commitment. In D. Elliott& J. E. Stern ( Eds.), Research ethics: A reader ( pp. 165-189). Hanover, NH: University Press of New England.
168. Wester, K. L., Willse, J. T.,& Davis, M. S. (2008). Responsible conduct of research measure: Initial development and pilot study. Accountability in Research, 15, 87-104.
169. Williams, J. R. (2006). The physician's role in the protection of human research subjects. Science and Engineering Ethics, 12, 5-12. (Pubitemid 43242424)
170. Wilson, K., Schreier, A., Griffin, A.,& Resnik, D. (2007). Research records and the resolution of misconduct allegations at research institutions. Accountability in Research, 14(1), 57-71.
171. Woolf, P. K. (1986, February). Pressure to publish and fraud in science. Annals of Internal Medicine, 104, 254-256. (Pubitemid 16134717)
172. World Medical Association. (2008). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted by the 59th World Medical Association General Assembly, Seoul, Korea. Retrieved from http://www.Wma.net/en/30publications/10policies/ b3/index.html.
173. Wright, D. E., Titus, S. L.,& Cornelison, J. B. (2008). Mentoring and research misconduct: An analysis of research mentoring in closed ORI cases. Science and Engineering Ethics, 14, 323-336.
174. Yank, V.,& Barnes, D. (2003). Consensus and contention regarding redundant publications in clinical research: Cross-sectional survey of editors and authors. Journal of Medical Ethics, 29, 109-114. (Pubitemid 36504107)